Showing results (251-260 of 293) with videos related to

Sort By:
Pageof 30
Plos Biology|January 12, 2016
FIH Regulates Cellular Metabolism through Hydroxylation of the Deubiquitinase OTUB1Carsten C Scholz, Javier Rodriguez, Christina Pickel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of liver dysfunction: a study by the National Cancer Institute Organ Dysfunction Working GroupRamesh K Ramanathan, Merrill J Egorin, Chris H M Takimoto, et al.
Investigational New Drugs|July 18, 2013
A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumorsIvan Diaz-Padilla, Hal Hirte, Amit M Oza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2022
Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part SarcomaJames Nguyen, Naoko Takebe, Shivaani Kummar, et al.
Investigational New Drugs|May 3, 2014
A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patientsAnna Spreafico, Kim N Chi, Srikala S Sridhar, et al.
Molecular Cancer Therapeutics|February 13, 2023
A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE)Elizabeth Pan, Wanling Xie, Archana Ajmera, et al.
Investigational New Drugs|August 1, 2012
A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumorsAmir Mortazavi, Yonghua Ling, Ludmila Katherine Martin, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 29, 2021
Clinical consequences of consecutive self-expanding transcatheter heart valve iterationsH G Kroon, L van Gils, F Ziviello, et al.
NPJ Precision Oncology|December 5, 2017
Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survivalOvidiu C Andronesi, Morteza Esmaeili, Ronald J H Borra, et al.
Breast Cancer Research and Treatment|February 28, 2023
A phase 1 study of veliparib (ABT-888) plus weekly carboplatin and paclitaxel in advanced solid malignancies, with an expansion cohort in triple negative breast cancer (TNBC) (ETCTN 8620)Monica K Malhotra, Shalu Pahuja, Brian F Kiesel, et al.
Pageof 30